{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"spasticity-ataxia-gait-anomalies","columns":[{"gene":"","key":"population-319272cb457cfa83e79f","label":"Spasticity, childhood-onset, with hyperglycinemia","mondoId":"MONDO:0014803","onsetQualifier":null,"originColumnKey":"MONDO:0014803/OMIM:616859","originalViews":[{"key":"MONDO:0014803/OMIM:616859","label":"Spasticity, childhood-onset, with hyperglycinemia","scopeLabel":"OMIM:616859","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["03bf3e2966ccd3390a67d39bfff9332a6fd6324f22ce8060f3a9ef2bb743681f","08c8723d7c8965e12178ca8782d04ca81d4a9f5778d18a970c1e65fcab36c984","2c93cfb2e6c82b9a1f5463b868ca1f80239371e8a5f0e5fa4868b89935b4cf94","33a500e5501e9518a9550beef8896d17d9783b9bee76d7e6d6999290a8d68d64","388e5f079d4a52edf1de25390ee2abbf0ad5223bf57202739d91bc0744d3d36d","3ed81f4f6eb459d92334457603576cf6070688c87638173462f44466043786a8","47f1543efb138db81c727bfbc83da4a47d916b05174b35c0a910619b77662047","514dc4a88c1b26b488b08d6c30617ed6daceeb4246bfb782f7ee4e0a3490e3b9","61a662e9c9856a4587a49797c2730f4381ac19ab09053b392715f181a77682b6","63b8fef212e04aa45e80597aa866e31c55733474e60e28eb800d08ef2ff5d042","6426ca301346dacfd133f7d659526a717ed337a2acc99cda8c654cd9217e14db","67759476488812f3d680b4becd3788b37da90d0bcea5e4d271d0d9286cd96d0a","7fae89d6c408ab53bf74be22f64d2d6feeb17d38e29d87770df1903a5abd5a18","832202da755130f4dfdb782bc19fe874707119da9030b768d0d139115a50d9cf","8bb554782922240fca3869d3408f9788f1ec33e857040db249fdad50c6adbd47","97e812ceec92aa46c263e43ed86c18aaa9eaa5b8168fe507fda7b022bd170931","ca416cc52b445a730220a097d459653e9d2f31c1323bd6e51ebeecb9b8406ae7","cffefb521a2f71eaab041592f065a04745b057dac87b4107cdfd07cd6adc586c","d50b088e6ad877b7a5dac570696eba5b0a8d99c3f3c369f8a3cf0ee1e3de425f","e9eeda883eead7306fa4ffc3db8d300e33e6833e75dc71c87d31ae634ade3a33","ff69fb005c9370b30badbc1ad7d6c9f4936447302ecf1f6645d40ac2c27bf829"],"recordQualifiers":{},"scopeLabel":"OMIM:616859","sourceIds":["OMIM:616859"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."},{"gene":"","key":"population-4e7db8d4cc481bd84322","label":"Childhood-onset spasticity with hyperglycinemia","mondoId":"MONDO:0014803","onsetQualifier":null,"originColumnKey":"MONDO:0014803/ORPHA:401866","originalViews":[{"key":"MONDO:0014803/ORPHA:401866","label":"Childhood-onset spasticity with hyperglycinemia","scopeLabel":"ORPHA:401866","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["00d47bac24f37a8aed02dd1eb19fb1827ce241cefdc0e22a8eb9b50722d2a8a7","02564df85e56d9f77bf517d0765f0977275dff0c3b2e45a818d5597d38bba5e9","0c4aa4d9aedbb5f6972b066b3bce1f75c3192ee0ceb1565931c3db8d84e2345a","1ce660963f82bff74c951b6b486ba2f9bec9a8e1dafb8a834d92ac0d4728e683","22cf057c89ae3daa59ac69f4cdcc7c112666617257d68ee66a1c97fd39124b53","2759904156fc76e18fee04d4a58a1e653b81cc03b6f47258a6a30d36a3b528e4","3120e04e185bcc9408ad2768a881155d3bf593264215774fbe6ea4b50fa1ed21","352199d75a420affa925481bf4a2506205ca40bd2cb5dbb75408cbf1f1bef405","39899c02e57fc19f4d67ab497ea8d51f4644d3f66323533253fc21ca3d2f106f","3d396e4fabd0ded0d66d641c690c4ec93f36525fa6de0e19d1c8ec8dd86b80df","3d7af4071cabc04ddfc74f9288f6b188cbc10285567d20f42031c3526a35b509","49d813283d57041c26acc3e775aa2abb8bb8a4659c3c36f1bb056f58fbb9535e","4b67177e19246d0fb2522e870f43d3952bfb8a87fa197b5a10b0a9aec68bf0e1","53f87d0108236119fec61a6e53abefdeb293f097cdd6052401420fbe136e71a1","585ce9fb7ead585f0c26244448366bc639aed5c67c2828b74b0376146318aec8","5e30c82cbf0704ca552a814c112fe4f1f5e11f34ca8ac8611ccd333f8a3d9493","6ea69c079b52b242b40bbc2569efb2b1a46cda0a84cb66381893ff44117381a4","720eda2490cbfcfc348c88ac038ed8156fd9da937f2fc266bfef2c40cd03b97b","7ec378de35a5e07f84ae299d6b0d6f52b03020a87328042acfbd497d8621be56","8ebb0ea134329dc07153d99dae667fbbb2bfff4fc7bd542e779b8d4f7e5ad36a","a63f931b30caa6d9d649b0139ff260359bae71166d54bccd71d6a1745f4118b6","b0cbeda277e87d0ba87d65f0ea004fef7f4e36816d8e189c1ec4abed8bb9214b","bdde8af9f56a5d2c2291f8ce56c520ed4a1925a1967d242aa9651ecaee7e14fa","bde57e2e22d9a892990a78fe43560e5d0859105c379784d3fc7b95de3bfc2f00","dfc2074ce7b9e982373ea95f0ec3cab1fa82fdd4213309de2ddc99127a03cc3d"],"recordQualifiers":{},"scopeLabel":"ORPHA:401866","sourceIds":["ORPHA:401866"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-319272cb457cfa83e79f","population-4e7db8d4cc481bd84322"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0007256","HP:0001251","HP:0003487","HP:0100543","HP:0002928","HP:0002376","HP:0001260"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":5,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":46,"sourceGroups":{"omim":1,"orphanet":25,"published":20}},"features":[{"hpoId":"HP:0007256","label":"Abnormal pyramidal sign","primary":true},{"hpoId":"HP:0001251","label":"Ataxia","primary":true},{"hpoId":"HP:0003487","label":"Babinski sign","primary":true},{"hpoId":"HP:0100543","label":"Cognitive impairment","primary":true},{"hpoId":"HP:0002928","label":"Decreased activity of the pyruvate dehydrogenase complex","primary":true},{"hpoId":"HP:0002376","label":"Developmental regression","primary":true},{"hpoId":"HP:0001260","label":"Dysarthria","primary":true},{"hpoId":"HP:0011968","label":"Feeding difficulties","primary":false},{"hpoId":"HP:0001288","label":"Gait disturbance","primary":false},{"hpoId":"HP:0001290","label":"Generalized hypotonia","primary":false},{"hpoId":"HP:0002154","label":"Hyperglycinemia","primary":false},{"hpoId":"HP:0001347","label":"Hyperreflexia","primary":false},{"hpoId":"HP:0001276","label":"Hypertonia","primary":false},{"hpoId":"HP:0002079","label":"Hypoplasia of the corpus callosum","primary":false},{"hpoId":"HP:0002151","label":"Increased circulating lactate concentration","primary":false},{"hpoId":"HP:0500230","label":"Increased CSF glycine concentration","primary":false},{"hpoId":"HP:0002490","label":"Increased CSF lactate","primary":false},{"hpoId":"HP:0000737","label":"Irritability","primary":false},{"hpoId":"HP:0001712","label":"Left ventricular hypertrophy","primary":false},{"hpoId":"HP:0002415","label":"Leukodystrophy","primary":false},{"hpoId":"HP:0008945","label":"Loss of ability to walk in early childhood","primary":false},{"hpoId":"HP:0001336","label":"Myoclonus","primary":false},{"hpoId":"HP:0008288","label":"Nonketotic hyperglycinemia","primary":false},{"hpoId":"HP:0000639","label":"Nystagmus","primary":false},{"hpoId":"HP:0000648","label":"Optic atrophy","primary":false},{"hpoId":"HP:0002191","label":"Progressive spasticity","primary":false},{"hpoId":"HP:6000829","label":"Reduced tissue glycine cleavage enzyme activity","primary":false},{"hpoId":"HP:0001250","label":"Seizure","primary":false},{"hpoId":"HP:0000736","label":"Short attention span","primary":false},{"hpoId":"HP:0002497","label":"Spastic ataxia","primary":false},{"hpoId":"HP:0001264","label":"Spastic diplegia","primary":false},{"hpoId":"HP:0002464","label":"Spastic dysarthria","primary":false},{"hpoId":"HP:0001257","label":"Spasticity","primary":false},{"hpoId":"HP:0100561","label":"Spinal cord lesion","primary":false},{"hpoId":"HP:0000486","label":"Strabismus","primary":false},{"hpoId":"HP:0002317","label":"Unsteady gait","primary":false},{"hpoId":"HP:0000505","label":"Visual impairment","primary":false}],"ledeHtml":"Childhood-onset spasticity with hyperglycinemia is a rare neurometabolic disease characterized by a childhood onset of progressive spastic ataxia associated with gait disturbances, hyperreflexia, extensor plantar responses and non-ketotic hyperglycinemia typically revealed by biochemical analysis. Additional signs of upper extremity spasticity, dysarthria, learning difficulties, poor concentration, nystagmus, optic atrophy and reduced visual acuity may also be associated.","mondoId":"MONDO:0014803","node":{"canonicalSlug":"spasticity-ataxia-gait-anomalies","comparisons":[{"documentSha256":"7cb024a9449023efe42e82f751fc8050beb60f904b4c56bea1d2faada91f9701","key":"expanded-inherited-lipoic-acid-biosynthesis-defect","kind":"expanded","label":"inherited lipoic acid biosynthesis defect","memberIds":["MONDO:0009529","MONDO:0011582","MONDO:0013675","MONDO:0013762","MONDO:0014132","MONDO:0014576","MONDO:0014611","MONDO:0014803","MONDO:0015003","MONDO:0017338","MONDO:0018424","MONDO:0020714","MONDO:0033282","MONDO:0054785","MONDO:0060582","MONDO:0957382","MONDO:0971174","MONDO:0975806"],"mondoId":"MONDO:0018424","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-7cb024a9449023efe42e.7cb024a9449023efe42e82f751fc8050beb60f904b4c56bea1d2faada91f9701.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Spasticity-ataxia-gait anomalies syndrome","originalSourceId":"ORPHA:401866","paragraphs":["Childhood-onset spasticity with hyperglycinemia is a rare neurometabolic disease characterized by a childhood onset of progressive spastic ataxia associated with gait disturbances, hyperreflexia, extensor plantar responses and non-ketotic hyperglycinemia typically revealed by biochemical analysis. Additional signs of upper extremity spasticity, dysarthria, learning difficulties, poor concentration, nystagmus, optic atrophy and reduced visual acuity may also be associated."],"rawAttribution":"ORPHA:401866","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:41:42Z","upstream":"ORPHA:401866","url":"https://rarediseases.info.nih.gov/diseases/12681"},"ownColumnKeys":["population-319272cb457cfa83e79f","population-4e7db8d4cc481bd84322"],"publication":"published","relationships":[{"kind":"parent","label":"spastic ataxia","mondoId":"MONDO:0017845","slug":null},{"kind":"parent","label":"inherited lipoic acid biosynthesis defect","mondoId":"MONDO:0018424","slug":"inherited-lipoic-acid-biosynthesis-defect"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"00d47bac24f37a8aed02dd1eb19fb1827ce241cefdc0e22a8eb9b50722d2a8a7","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:401866","disease_name":"Childhood-onset spasticity with hyperglycinemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001290","is_excluded":false,"label":"Generalized hypotonia","onset_id":null,"reference":"ORPHA:401866","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"02564df85e56d9f77bf517d0765f0977275dff0c3b2e45a818d5597d38bba5e9","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:401866","disease_name":"Childhood-onset spasticity with hyperglycinemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002317","is_excluded":false,"label":"Unsteady gait","onset_id":null,"reference":"ORPHA:401866","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"03bf3e2966ccd3390a67d39bfff9332a6fd6324f22ce8060f3a9ef2bb743681f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616859","disease_name":"Spasticity, childhood-onset, with hyperglycinemia","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0001288","is_excluded":false,"label":"Gait disturbance","onset_id":null,"reference":"PMID:21471552","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"08c8723d7c8965e12178ca8782d04ca81d4a9f5778d18a970c1e65fcab36c984","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:616859","disease_name":"Spasticity, childhood-onset, with hyperglycinemia","evidence":"PCS","frequency_raw":"4/8","hpo_id":"HP:0500230","is_excluded":false,"label":"Increased CSF glycine concentration","onset_id":null,"reference":"PMID:24334290","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"0c4aa4d9aedbb5f6972b066b3bce1f75c3192ee0ceb1565931c3db8d84e2345a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:401866","disease_name":"Childhood-onset spasticity with hyperglycinemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0008945","is_excluded":false,"label":"Loss of ability to walk in early childhood","onset_id":null,"reference":"ORPHA:401866","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"1ce660963f82bff74c951b6b486ba2f9bec9a8e1dafb8a834d92ac0d4728e683","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:401866","disease_name":"Childhood-onset spasticity with hyperglycinemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0011968","is_excluded":false,"label":"Feeding difficulties","onset_id":null,"reference":"ORPHA:401866","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"22cf057c89ae3daa59ac69f4cdcc7c112666617257d68ee66a1c97fd39124b53","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:401866","disease_name":"Childhood-onset spasticity with hyperglycinemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002464","is_excluded":false,"label":"Spastic dysarthria","onset_id":null,"reference":"ORPHA:401866","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2759904156fc76e18fee04d4a58a1e653b81cc03b6f47258a6a30d36a3b528e4","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:401866","disease_name":"Childhood-onset spasticity with hyperglycinemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000737","is_excluded":false,"label":"Irritability","onset_id":null,"reference":"ORPHA:401866","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"2c93cfb2e6c82b9a1f5463b868ca1f80239371e8a5f0e5fa4868b89935b4cf94","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:616859","disease_name":"Spasticity, childhood-onset, with hyperglycinemia","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0000486","is_excluded":false,"label":"Strabismus","onset_id":null,"reference":"PMID:21471552","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"3120e04e185bcc9408ad2768a881155d3bf593264215774fbe6ea4b50fa1ed21","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:401866","disease_name":"Childhood-onset spasticity with hyperglycinemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0100561","is_excluded":false,"label":"Spinal cord lesion","onset_id":null,"reference":"ORPHA:401866","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"33a500e5501e9518a9550beef8896d17d9783b9bee76d7e6d6999290a8d68d64","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616859","disease_name":"Spasticity, childhood-onset, with hyperglycinemia","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0002079","is_excluded":false,"label":"Hypoplasia of the corpus callosum","onset_id":null,"reference":"PMID:21471552","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"352199d75a420affa925481bf4a2506205ca40bd2cb5dbb75408cbf1f1bef405","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:401866","disease_name":"Childhood-onset spasticity with hyperglycinemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002415","is_excluded":false,"label":"Leukodystrophy","onset_id":null,"reference":"ORPHA:401866","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"388e5f079d4a52edf1de25390ee2abbf0ad5223bf57202739d91bc0744d3d36d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616859","disease_name":"Spasticity, childhood-onset, with hyperglycinemia","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0001257","is_excluded":false,"label":"Spasticity","onset_id":null,"reference":"PMID:21471552","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"39899c02e57fc19f4d67ab497ea8d51f4644d3f66323533253fc21ca3d2f106f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:401866","disease_name":"Childhood-onset spasticity with hyperglycinemia","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002191","is_excluded":false,"label":"Progressive spasticity","onset_id":null,"reference":"ORPHA:401866","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3d396e4fabd0ded0d66d641c690c4ec93f36525fa6de0e19d1c8ec8dd86b80df","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:401866","disease_name":"Childhood-onset spasticity with hyperglycinemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002928","is_excluded":false,"label":"Decreased activity of the pyruvate dehydrogenase complex","onset_id":null,"reference":"ORPHA:401866","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3d7af4071cabc04ddfc74f9288f6b188cbc10285567d20f42031c3526a35b509","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:401866","disease_name":"Childhood-onset spasticity with hyperglycinemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001251","is_excluded":false,"label":"Ataxia","onset_id":null,"reference":"ORPHA:401866","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"3ed81f4f6eb459d92334457603576cf6070688c87638173462f44466043786a8","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:616859","disease_name":"Spasticity, childhood-onset, with hyperglycinemia","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0002928","is_excluded":false,"label":"Decreased activity of the pyruvate dehydrogenase complex","onset_id":null,"reference":"PMID:24334290","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"47f1543efb138db81c727bfbc83da4a47d916b05174b35c0a910619b77662047","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:616859","disease_name":"Spasticity, childhood-onset, with hyperglycinemia","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000505","is_excluded":false,"label":"Visual impairment","onset_id":null,"reference":"OMIM:616859","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"49d813283d57041c26acc3e775aa2abb8bb8a4659c3c36f1bb056f58fbb9535e","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:401866","disease_name":"Childhood-onset spasticity with hyperglycinemia","evidence":"TAS","frequency_raw":"HP:0040284","hpo_id":"HP:0001712","is_excluded":false,"label":"Left ventricular hypertrophy","onset_id":null,"reference":"ORPHA:401866","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4b67177e19246d0fb2522e870f43d3952bfb8a87fa197b5a10b0a9aec68bf0e1","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:401866","disease_name":"Childhood-onset spasticity with hyperglycinemia","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0008288","is_excluded":false,"label":"Nonketotic hyperglycinemia","onset_id":null,"reference":"ORPHA:401866","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"514dc4a88c1b26b488b08d6c30617ed6daceeb4246bfb782f7ee4e0a3490e3b9","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616859","disease_name":"Spasticity, childhood-onset, with hyperglycinemia","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0001347","is_excluded":false,"label":"Hyperreflexia","onset_id":null,"reference":"PMID:21471552","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"53f87d0108236119fec61a6e53abefdeb293f097cdd6052401420fbe136e71a1","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:401866","disease_name":"Childhood-onset spasticity with hyperglycinemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001264","is_excluded":false,"label":"Spastic diplegia","onset_id":null,"reference":"ORPHA:401866","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"585ce9fb7ead585f0c26244448366bc639aed5c67c2828b74b0376146318aec8","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:401866","disease_name":"Childhood-onset spasticity with hyperglycinemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0003487","is_excluded":false,"label":"Babinski sign","onset_id":null,"reference":"ORPHA:401866","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5e30c82cbf0704ca552a814c112fe4f1f5e11f34ca8ac8611ccd333f8a3d9493","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:401866","disease_name":"Childhood-onset spasticity with hyperglycinemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002376","is_excluded":false,"label":"Developmental regression","onset_id":null,"reference":"ORPHA:401866","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"61a662e9c9856a4587a49797c2730f4381ac19ab09053b392715f181a77682b6","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:616859","disease_name":"Spasticity, childhood-onset, with hyperglycinemia","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0000648","is_excluded":false,"label":"Optic atrophy","onset_id":null,"reference":"PMID:21471552","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"63b8fef212e04aa45e80597aa866e31c55733474e60e28eb800d08ef2ff5d042","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616859","disease_name":"Spasticity, childhood-onset, with hyperglycinemia","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0002415","is_excluded":false,"label":"Leukodystrophy","onset_id":null,"reference":"PMID:21471552","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"6426ca301346dacfd133f7d659526a717ed337a2acc99cda8c654cd9217e14db","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:616859","disease_name":"Spasticity, childhood-onset, with hyperglycinemia","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0000639","is_excluded":false,"label":"Nystagmus","onset_id":null,"reference":"PMID:21471552","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"67759476488812f3d680b4becd3788b37da90d0bcea5e4d271d0d9286cd96d0a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616859","disease_name":"Spasticity, childhood-onset, with hyperglycinemia","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"PMID:24334290","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"6ea69c079b52b242b40bbc2569efb2b1a46cda0a84cb66381893ff44117381a4","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:401866","disease_name":"Childhood-onset spasticity with hyperglycinemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001276","is_excluded":false,"label":"Hypertonia","onset_id":null,"reference":"ORPHA:401866","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"720eda2490cbfcfc348c88ac038ed8156fd9da937f2fc266bfef2c40cd03b97b","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:401866","disease_name":"Childhood-onset spasticity with hyperglycinemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000648","is_excluded":false,"label":"Optic atrophy","onset_id":null,"reference":"ORPHA:401866","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7ec378de35a5e07f84ae299d6b0d6f52b03020a87328042acfbd497d8621be56","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:401866","disease_name":"Childhood-onset spasticity with hyperglycinemia","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001336","is_excluded":false,"label":"Myoclonus","onset_id":null,"reference":"ORPHA:401866","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"7fae89d6c408ab53bf74be22f64d2d6feeb17d38e29d87770df1903a5abd5a18","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:616859","disease_name":"Spasticity, childhood-onset, with hyperglycinemia","evidence":"PCS","frequency_raw":"8/8","hpo_id":"HP:0002154","is_excluded":false,"label":"Hyperglycinemia","onset_id":null,"reference":"PMID:21471552","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"832202da755130f4dfdb782bc19fe874707119da9030b768d0d139115a50d9cf","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616859","disease_name":"Spasticity, childhood-onset, with hyperglycinemia","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0001264","is_excluded":false,"label":"Spastic diplegia","onset_id":null,"reference":"PMID:24334290","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"8bb554782922240fca3869d3408f9788f1ec33e857040db249fdad50c6adbd47","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616859","disease_name":"Spasticity, childhood-onset, with hyperglycinemia","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0001260","is_excluded":false,"label":"Dysarthria","onset_id":null,"reference":"PMID:24334290","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"8ebb0ea134329dc07153d99dae667fbbb2bfff4fc7bd542e779b8d4f7e5ad36a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:401866","disease_name":"Childhood-onset spasticity with hyperglycinemia","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0100543","is_excluded":true,"label":"Cognitive impairment","onset_id":null,"reference":"ORPHA:401866","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"97e812ceec92aa46c263e43ed86c18aaa9eaa5b8168fe507fda7b022bd170931","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616859","disease_name":"Spasticity, childhood-onset, with hyperglycinemia","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0003487","is_excluded":false,"label":"Babinski sign","onset_id":null,"reference":"PMID:21471552","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"a63f931b30caa6d9d649b0139ff260359bae71166d54bccd71d6a1745f4118b6","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:401866","disease_name":"Childhood-onset spasticity with hyperglycinemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000505","is_excluded":false,"label":"Visual impairment","onset_id":null,"reference":"ORPHA:401866","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b0cbeda277e87d0ba87d65f0ea004fef7f4e36816d8e189c1ec4abed8bb9214b","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:401866","disease_name":"Childhood-onset spasticity with hyperglycinemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001347","is_excluded":false,"label":"Hyperreflexia","onset_id":null,"reference":"ORPHA:401866","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bdde8af9f56a5d2c2291f8ce56c520ed4a1925a1967d242aa9651ecaee7e14fa","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:401866","disease_name":"Childhood-onset spasticity with hyperglycinemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000736","is_excluded":false,"label":"Short attention span","onset_id":null,"reference":"ORPHA:401866","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bde57e2e22d9a892990a78fe43560e5d0859105c379784d3fc7b95de3bfc2f00","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:401866","disease_name":"Childhood-onset spasticity with hyperglycinemia","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000639","is_excluded":false,"label":"Nystagmus","onset_id":null,"reference":"ORPHA:401866","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"ca416cc52b445a730220a097d459653e9d2f31c1323bd6e51ebeecb9b8406ae7","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:616859","disease_name":"Spasticity, childhood-onset, with hyperglycinemia","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:6000829","is_excluded":false,"label":"Reduced tissue glycine cleavage enzyme activity","onset_id":null,"reference":"PMID:24334290","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"cffefb521a2f71eaab041592f065a04745b057dac87b4107cdfd07cd6adc586c","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:616859","disease_name":"Spasticity, childhood-onset, with hyperglycinemia","evidence":"PCS","frequency_raw":"2/7","hpo_id":"HP:0002490","is_excluded":false,"label":"Increased CSF lactate","onset_id":null,"reference":"PMID:24334290","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"d50b088e6ad877b7a5dac570696eba5b0a8d99c3f3c369f8a3cf0ee1e3de425f","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:616859","disease_name":"Spasticity, childhood-onset, with hyperglycinemia","evidence":"PCS","frequency_raw":"4/7","hpo_id":"HP:0002151","is_excluded":false,"label":"Increased circulating lactate concentration","onset_id":null,"reference":"PMID:24334290","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"dfc2074ce7b9e982373ea95f0ec3cab1fa82fdd4213309de2ddc99127a03cc3d","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:401866","disease_name":"Childhood-onset spasticity with hyperglycinemia","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002151","is_excluded":true,"label":"Increased circulating lactate concentration","onset_id":null,"reference":"ORPHA:401866","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"e9eeda883eead7306fa4ffc3db8d300e33e6833e75dc71c87d31ae634ade3a33","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616859","disease_name":"Spasticity, childhood-onset, with hyperglycinemia","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0007256","is_excluded":false,"label":"Abnormal pyramidal sign","onset_id":null,"reference":"PMID:24334290","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"ff69fb005c9370b30badbc1ad7d6c9f4936447302ecf1f6645d40ac2c27bf829","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:616859","disease_name":"Spasticity, childhood-onset, with hyperglycinemia","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0002497","is_excluded":false,"label":"Spastic ataxia","onset_id":null,"reference":"PMID:24334290","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/12681\" rel=\"noreferrer\">GARD</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:401866</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Childhood-onset spasticity with hyperglycinemia is a rare neurometabolic disease characterized by a childhood onset of progressive spastic ataxia associated with gait disturbances, hyperreflexia, extensor plantar responses and non-ketotic hyperglycinemia typically revealed by biochemical analysis. Additional signs of upper extremity spasticity, dysarthria, learning difficulties, poor concentration, nystagmus, optic atrophy and reduced visual acuity may also be associated.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/12681\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"spasticity-ataxia-gait-anomalies","sourceDocuments":[{"name":"GARD: Spasticity-ataxia-gait anomalies syndrome","reviewed":null,"source_release":"2026-10-25T03:41:42Z","url":"https://rarediseases.info.nih.gov/diseases/12681"}],"sourceNote":"","synonyms":["childhood-onset spasticity with variant non-ketotic hyperglycinemia","SPAHGC","spasticity, childhood-onset, with hyperglycinemia"],"takeawayHtml":"","title":"spasticity-ataxia-gait anomalies syndrome"},"schemaVersion":1}
